logo
Select company
Select metric
$ -2.47MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
39
Sector
44
Industry
48
History
58
$ 3.22Close
$ 0.9 - $ 6.06 52-Week Range
Ticker Information

Ticker

ALEC

Company Name

ALECTOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALECTOR INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALEC - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -2.47M
3/31/2025$ -34.28M
12/31/2024$ -41.23M
9/30/2024$ -64.81M
6/30/2024$ -84M
3/31/2024$ -122.93M
12/31/2023$ -79.69M
9/30/2023$ -82.19M
6/30/2023$ -40.65M
3/31/2023$ -259.06M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALECTOR INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -2M.
  • Over the past 5 years, ALECTOR INC's average CF - Chg. Cash has been $ -13.8M.
  • The median CF - Chg. Cash for ALECTOR INC during this period was $ -40.94M
  • ALECTOR INC reached its highest CF - Chg. Cash over the past 5 years at $ 431.55M.
  • The lowest CF - Chg. Cash recorded by ALECTOR INC in the same timeframe $ -332.3M

ALECTOR INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
SGMO : SANGAMO THERAPEUTICS INC $ 12.06MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -2.82MTHTX : THERATECHNOLOGIES INC $ -15.86MENTA : ENANTA PHARMACEUTICALS INC $ 8.43MAGEN : AGENUS INC $ -84.19MPLX : PROTALIX BIOTHERAPEUTICS INC $ -5.5MSPRO : SPERO THERAPEUTICS INC $ -32.33MCSBR : CHAMPIONS ONCOLOGY INC $ 7.43MTRDA : ENTRADA THERAPEUTICS INC $ -112.77MCELU : CELULARITY INC $ 382K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

ALEC - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -332.3M

Minimum

Sep 30, 2022

$ 431.55M

Maximum

Sep 30, 2021

$ -13.8M

Average

$ -40.94M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.19M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.19M
median$ 116.12K
std$ 44.92M